Bevacizumab as adjuvant treatment of colon cancer: Updated results from the S-AVANT phase III study by the GERCOR group
Andre, T., Vernerey, D., Im, S. A., Bodoky, G., Buzzoni, R., Reingold, S., Tabernero, J., et al. (2020). Bevacizumab as … Read More
